• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个关于 AMPK 在前列腺癌中的调控、作用和靶向的时空假说。

A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.

机构信息

Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, 3517 Cullen Boulevard, Houston, Texas 77204, USA.

Molecular Medicine Program, The Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030, USA.

出版信息

Nat Rev Urol. 2017 Mar;14(3):164-180. doi: 10.1038/nrurol.2016.272. Epub 2017 Feb 1.

DOI:10.1038/nrurol.2016.272
PMID:28169991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5672799/
Abstract

The 5'-AMP-activated protein kinase (AMPK) is a master regulator of cellular homeostasis. Despite AMPK's known function in physiology, its role in pathological processes such as prostate cancer is enigmatic. However, emerging evidence is now beginning to decode the paradoxical role of AMPK in cancer and, therefore, inform clinicians if - and how - AMPK could be therapeutically targeted. Spatiotemporal regulation of AMPK complexes could be one of the mechanisms that governs this kinase's role in cancer. We hypothesize that different upstream stimuli will activate select subcellular AMPK complexes. This hypothesis is supported by the distinct subcellular locations of the various AMPK subunits. Each of these unique AMPK complexes regulates discrete downstream processes that can be tumour suppressive or oncogenic. AMPK's final biological output is then determined by the weighted net function of these downstream signalling events, influenced by additional prostate-specific signalling.

摘要

5'- 腺苷酸活化蛋白激酶 (AMPK) 是细胞内稳态的主要调节因子。尽管 AMPK 的生理功能已被广泛研究,但它在前列腺癌等病理过程中的作用仍不明确。然而,新出现的证据现在开始揭示 AMPK 在癌症中的矛盾作用,并因此告知临床医生,如果可以的话,AMPK 如何进行治疗性靶向。AMPK 复合物的时空调节可能是控制该激酶在癌症中作用的机制之一。我们假设不同的上游刺激将激活特定的细胞内 AMPK 复合物。这一假设得到了不同 AMPK 亚基的独特细胞内位置的支持。这些独特的 AMPK 复合物中的每一个都调节离散的下游过程,这些过程可能具有肿瘤抑制或致癌作用。AMPK 的最终生物学输出取决于这些下游信号事件的加权净功能,受额外的前列腺特异性信号的影响。

相似文献

1
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.一个关于 AMPK 在前列腺癌中的调控、作用和靶向的时空假说。
Nat Rev Urol. 2017 Mar;14(3):164-180. doi: 10.1038/nrurol.2016.272. Epub 2017 Feb 1.
2
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.靶向5'-AMP激活的蛋白激酶及相关代谢途径治疗前列腺癌。
Expert Opin Ther Targets. 2015 May;19(5):617-32. doi: 10.1517/14728222.2015.1005603. Epub 2015 Jan 20.
3
Potential upstream regulators and downstream targets of AMP-activated kinase signaling during oocyte maturation in a marine worm.海洋蠕虫卵母细胞成熟过程中 AMP 激活的蛋白激酶信号的潜在上游调控因子和下游靶标。
Reproduction. 2011 Jul;142(1):29-39. doi: 10.1530/REP-10-0509. Epub 2011 Apr 7.
4
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.一种新型的AMPK直接激活剂通过阻断脂肪生成来抑制前列腺癌生长。
EMBO Mol Med. 2014 Apr;6(4):519-38. doi: 10.1002/emmm.201302734. Epub 2014 Feb 4.
5
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy.助力治疗前列腺癌:新型AMPK激活剂用于癌症治疗崭露头角。
EMBO Mol Med. 2014 Apr;6(4):439-41. doi: 10.1002/emmm.201303737. Epub 2014 Feb 20.
6
Metabolic alterations and targeted therapies in prostate cancer.前列腺癌的代谢改变与靶向治疗。
J Pathol. 2011 Jan;223(2):283-94. doi: 10.1002/path.2809. Epub 2010 Nov 16.
7
AMPK's double-faced role in advanced stages of prostate cancer.AMPK 在前列腺癌晚期的双重角色。
Clin Transl Oncol. 2022 Nov;24(11):2064-2073. doi: 10.1007/s12094-022-02874-z. Epub 2022 Jul 4.
8
Promise and challenges for direct small molecule AMPK activators.直接小分子 AMPK 激活剂的前景与挑战。
Biochem Pharmacol. 2018 Jul;153:147-158. doi: 10.1016/j.bcp.2018.01.049. Epub 2018 Feb 3.
9
Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.具有抗癌特性的明确复方草药混合物对去势抵抗性前列腺癌中 AMPK 的激活的 LKB1 和 CaMKK2 的同时调控。
BMC Complement Altern Med. 2018 Jun 18;18(1):188. doi: 10.1186/s12906-018-2255-0.
10
Activation of AMP-activated protein kinase by 3,3'-Diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo.3,3'-二吲哚甲烷(DIM)激活 AMP 激活的蛋白激酶与体外和体内人前列腺癌细胞死亡有关。
PLoS One. 2012;7(10):e47186. doi: 10.1371/journal.pone.0047186. Epub 2012 Oct 9.

引用本文的文献

1
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer.由CAMKK2-CREB信号传导调节的胆固醇代谢促进去势抵抗性前列腺癌。
Cell Rep. 2025 Jun 24;44(6):115792. doi: 10.1016/j.celrep.2025.115792. Epub 2025 Jun 7.
2
Energy Metabolism Profiling of Human Colorectal Tumours.人类结直肠癌的能量代谢分析
J Cell Mol Med. 2025 Mar;29(5):e70462. doi: 10.1111/jcmm.70462.
3
Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth.线粒体解偶联剂可抑制致癌性E2F1活性及前列腺癌生长。

本文引用的文献

1
Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?小鼠癌症模型中使用的二甲双胍剂量与临床相关吗?
Cell Metab. 2016 Apr 12;23(4):569-70. doi: 10.1016/j.cmet.2016.03.010.
2
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy.二甲双胍在小鼠肿瘤中的药代动力学:对人类治疗的启示。
Cell Metab. 2016 Apr 12;23(4):567-8. doi: 10.1016/j.cmet.2016.03.006.
3
AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment.
Cell Rep Med. 2025 Jan 21;6(1):101890. doi: 10.1016/j.xcrm.2024.101890. Epub 2025 Jan 9.
4
Metformin-based nanomedicines for reprogramming tumor immune microenvironment.用于重编程肿瘤免疫微环境的基于二甲双胍的纳米药物。
Theranostics. 2025 Jan 1;15(3):993-1016. doi: 10.7150/thno.104872. eCollection 2025.
5
Fine-tuning AMPK in physiology and disease using point-mutant mouse models.利用点突变小鼠模型精细调控 AMPK 在生理和疾病中的作用。
Dis Model Mech. 2024 Aug 1;17(8). doi: 10.1242/dmm.050798. Epub 2024 Aug 13.
6
Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.迷迭香酸通过抑制 Akt 并激活 AMPK 信号通路抑制前列腺癌细胞的存活和增殖。
Nutrients. 2024 Apr 24;16(9):1257. doi: 10.3390/nu16091257.
7
Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers.解锁前列腺癌中的铁死亡——通向新型治疗方法和成像标志物的道路。
Nat Rev Urol. 2024 Oct;21(10):615-637. doi: 10.1038/s41585-024-00869-9. Epub 2024 Apr 16.
8
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.一种抑制前列腺癌细胞糖酵解的化合物可控制晚期前列腺癌的生长。
Mol Cancer Ther. 2024 Jul 2;23(7):973-994. doi: 10.1158/1535-7163.MCT-23-0540.
9
Organelle proteomic profiling reveals lysosomal heterogeneity in association with longevity.细胞器蛋白质组学分析揭示了与长寿相关的溶酶体异质性。
Elife. 2024 Jan 19;13:e85214. doi: 10.7554/eLife.85214.
10
Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity.脂肪甘油三酯脂肪酶是晚期前列腺癌的治疗靶点,可促进代谢可塑性。
Cancer Res. 2024 Mar 4;84(5):703-724. doi: 10.1158/0008-5472.CAN-23-0555.
他莫昔芬通过雌激素受体非依赖机制激活AMPK并进行代谢重编程,提示这种治疗方式在癌症治疗中有新的用途。
Cancer Res. 2016 Jun 1;76(11):3295-306. doi: 10.1158/0008-5472.CAN-15-2197. Epub 2016 Mar 28.
4
CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas.CAMKK2 通过启动子甲基化调控,是弥漫性神经胶质瘤的预后标志物。
CNS Neurosci Ther. 2016 Jun;22(6):518-24. doi: 10.1111/cns.12531. Epub 2016 Mar 25.
5
Repurposing metformin for cancer treatment: current clinical studies.将二甲双胍重新用于癌症治疗:当前临床研究
Oncotarget. 2016 Jun 28;7(26):40767-40780. doi: 10.18632/oncotarget.8194.
6
Systematic meta-analyses of gene-specific genetic association studies in prostate cancer.前列腺癌基因特异性遗传关联研究的系统荟萃分析。
Oncotarget. 2016 Apr 19;7(16):22271-84. doi: 10.18632/oncotarget.7926.
7
Atg7 cooperates with Pten loss to drive prostate cancer tumor growth.自噬相关基因7(Atg7)与磷酸酶和张力蛋白同源物(Pten)缺失协同作用,促进前列腺癌肿瘤生长。
Genes Dev. 2016 Feb 15;30(4):399-407. doi: 10.1101/gad.274134.115.
8
Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress.代谢。AMP 活化蛋白激酶在能量应激反应中介导线粒体分裂。
Science. 2016 Jan 15;351(6270):275-281. doi: 10.1126/science.aab4138.
9
The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer.PGC-1α/ERRα 轴抑制一碳代谢并促进乳腺癌对叶酸类药物治疗的敏感性。
Cell Rep. 2016 Feb 2;14(4):920-931. doi: 10.1016/j.celrep.2015.12.086. Epub 2016 Jan 21.
10
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.易化葡萄糖转运蛋白:对癌症检测、预后及治疗的意义。
Metabolism. 2016 Feb;65(2):124-39. doi: 10.1016/j.metabol.2015.10.007. Epub 2015 Nov 13.